Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
NCT03588026
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Interventions
DRUG:
rVA576
OTHER:
Standard of care (SOC)
Sponsor
AKARI Therapeutics